Expanded Cord Blood Cell Infusion Following Combination Chemotherapy in Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT01701323 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Leukemia of Ambiguous Lineage
Acute Myeloid Leukemia

Interventions

BIOLOGICAL: Ex-Vivo Expanded Cord Blood Progenitor Cell Infusion
DRUG: Cytarabine
DRUG: Filgrastim
DRUG: Fludarabine Phosphate

Sponsor

Nohla Therapeutics, Inc.

Collaborators

[object Object]
[object Object]